Prescient Therapeutics Limited Stock
Stocks
PTX
AU000000PTX3
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0780 AUD | -4.88% |
|
-2.50% | -7.14% |
| 06-28 | Prescient Therapeutics Limited - Special Call | |
| 06-10 | Prescient Therapeutics Names Chief Medical Officer, Shares Jump 9% | MT |
| Market Cap | 64.14M 44.83M 39.29M 36.51M 33.5M 63.15M 4.33B 434M 170M 2.12B 168M 165M 7.31B | P/E 2024 |
-3.71x | P/E 2025 | -4.84x |
|---|---|---|---|---|---|
| Enterprise Value | 57.22M 39.99M 35.04M 32.57M 29.88M 56.33M 3.86B 387M 152M 1.89B 150M 147M 6.52B | EV / Sales 2024 |
4.42x | EV / Sales 2025 | 6.54x |
| Free-Float |
89.43% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Prescient Therapeutics Limited
| 1 day | -4.88% | ||
| 1 week | -2.50% | ||
| Current month | +27.87% | ||
| 1 month | +14.71% | ||
| 3 months | +52.94% | ||
| Current year | -7.14% |
| 1 week | 0.07 |  | 0.08 |
| 1 month | 0.06 | | 0.08 |
| Current year | 0.05 | | 0.1 |
| 1 year | 0.04 | | 0.12 |
| 3 years | 0.04 | | 0.12 |
| 5 years | 0.04 | | 0.3 |
| 10 years | 0.02 | | 0.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 2025-01-19 | |
Melanie Leydin
DFI | Director of Finance/CFO | 53 | - |
Rosalind Wilson
CTO | Chief Tech/Sci/R&D Officer | - | 2026-07-12 |
| Director | Title | Age | Since |
|---|---|---|---|
James Campbell
CHM | Chairman | - | 2025-03-29 |
Allen Ebens
BRD | Director/Board Member | - | 2020-05-31 |
Ellen Feigal
BRD | Director/Board Member | 71 | 2023-05-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/2/23 | Fiscal year | Chief Executive Officer | 1,148,936 | 0.1430% | ||
| 5/2/23 | Expiration | Chief Executive Officer | 2,351,064 | 0.2926% | ||
| 4/4/23 | Sell | Chief Executive Officer | 97,692 | 0.0135% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.88% | -2.50% | +69.57% | -2.50% | 60.44M | |
| -4.89% | -7.90% | -4.49% | +9.27% | 48.5B | |
| -0.14% | -1.05% | +376.39% | +583.71% | 38.97B | |
| +0.39% | +4.36% | +9.59% | +61.99% | 35.43B | |
| -1.54% | -4.48% | +24.89% | -13.03% | 33.65B | |
| -0.87% | -1.56% | -1.43% | +29.16% | 26.58B | |
| -1.28% | -5.14% | - | - | 16.82B | |
| -0.67% | -1.50% | +70.98% | +115.31% | 15.18B | |
| +1.32% | +2.29% | +14.62% | +15.52% | 13.89B | |
| +0.40% | -0.41% | +19.80% | -31.98% | 12.76B | |
| Average | -1.22% | -0.84% | +64.43% | +85.27% | 24.18B | |
| Weighted average by Cap. | -1.29% | -1.28% | +76.11% | +121.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.71M 2.59M 2.27M 2.11M 1.94M 3.65M 251M 25.14M 9.84M 123M 9.74M 9.53M 423M | 4.36M 3.04M 2.67M 2.48M 2.27M 4.29M 294M 29.5M 11.54M 144M 11.43M 11.18M 497M |
| Net income | -8.24M -5.76M -5.05M -4.69M -4.3M -8.11M -556M -55.79M -21.83M -272M -21.61M -21.14M -939M | -7.32M -5.12M -4.49M -4.17M -3.82M -7.21M -494M -49.59M -19.4M -242M -19.21M -18.79M -835M |
| Net Debt | -14.18M -9.91M -8.69M -8.07M -7.41M -13.96M -957M -96.05M -37.58M -469M -37.21M -36.4M -1.62B | -6.93M -4.84M -4.24M -3.94M -3.62M -6.82M -467M -46.91M -18.35M -229M -18.17M -17.78M -790M |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-22 | A$0.0780 | -4.88% | 90,694 |
| 26-07-21 | A$0.0820 | +2.50% | 1,184,372 |
| 26-07-20 | A$0.0800 | +9.59% | 1,020,011 |
| 26-07-17 | A$0.0730 | 0.00% | 786,045 |
| 26-07-16 | A$0.0730 | -4.58% | 311,895 |
- Stock Market
- Stocks
- PTX Stock
Select your edition
All financial news and data tailored to specific country editions
